Immunosuppression-free Nonvascularized Rectus Fascia Allotransplantation for Complex Hernia Repair

Area of Science:

• Surgical Innovation
• Transplantation Immunology
• Reconstructive Surgery

Background:

• Complex abdominal wall defects pose significant reconstructive challenges.
• Synthetic meshes risk infection, while biological meshes have inconsistent strength and high cost.
• Limited options exist for patients with contaminated fields or prior mesh failures.

Purpose of the Study:

• To investigate the feasibility and safety of nonvascularized rectus fascia allotransplantation (NVRF-alloTx) for abdominal wall reconstruction.
• To assess the immunologic profile of NVRF-alloTx in immunocompetent individuals.
• To evaluate NVRF-alloTx as a potential alternative to mesh-based repairs.

Main Methods:

• Prospective single-center case series of 3 immunocompetent patients.
• NVRF-alloTx performed for complex or contaminated abdominal wall defects unsuitable for mesh.
• Outcomes included durable closure, graft complications, and immunologic responses (donor-specific antibodies).

Main Results:

• All patients achieved successful abdominal wall closure with no hernia recurrence or graft failure.
• Two patients developed de novo anti-HLA donor-specific antibodies.
• Postmortem analysis of one graft showed robust integration and biomechanical properties similar to native fascia.

Conclusions:

• NVRF-alloTx without immunosuppression provides durable and mechanically stable abdominal wall reconstruction in high-risk patients.
• The procedure is a viable alternative in contaminated settings where mesh is contraindicated.
• Further studies are required to confirm long-term efficacy and outcomes.